-
公开(公告)号:US5849902A
公开(公告)日:1998-12-15
申请号:US754580
申请日:1996-11-21
申请人: Amy Arrow , Roderic M.K. Dale , Tod Mitchell Woolf
发明人: Amy Arrow , Roderic M.K. Dale , Tod Mitchell Woolf
IPC分类号: C12N15/09 , A61K31/7125 , A61K48/00 , C07H21/00 , C12N15/113 , C02Q1/68 , C07H21/04
CPC分类号: C12N15/113 , C12N2310/311 , C12N2310/315 , C12N2310/317 , C12N2310/321 , C12N2310/322 , C12N2310/346
摘要: This invention relates to antisense oligonucleotides that target mRNAs in cells as substrates for the cellular enzyme RNase H and thereby cause specific degradation of the targeted mRNA. The oligonucleotides have three components: a RNase H activating region, a complementarity region and 3' and 5' ends. The invention optimizes each of the components to resist intracellular nucleases, to increase hybridization to target mRNA, to specifically inactivate target mRNA in cells, and to decrease cytotoxicity.
-
公开(公告)号:US20080161257A1
公开(公告)日:2008-07-03
申请号:US11673486
申请日:2007-02-09
申请人: Roderic M.K. Dale , Amy Arrow , Terry Thompson
发明人: Roderic M.K. Dale , Amy Arrow , Terry Thompson
IPC分类号: A61K31/7088 , A61P3/00 , A61P19/00 , A61P25/00 , A61P17/00
CPC分类号: C12N15/1137 , A61K8/606 , A61K38/00 , A61K2800/74 , A61Q19/00 , C12N15/113 , C12N15/1136 , C12N15/1138 , C12N2310/11 , C12N2310/321 , C12N2320/35 , C12Y101/01088 , C12Y103/99005 , C12Y111/01006 , C12Y113/11012 , C12Y114/99001 , C12Y203/01026 , C12Y203/01085 , C12Y301/01003 , C12Y301/03048 , C12Y304/1401 , C12Y304/15001 , C12Y304/24011 , C12Y306/0301 , C12Y604/01002 , C12N2310/3521
摘要: The present invention relates to methods and compositions containing oligonucleotides suitable for administration to humans and other mammals.
-
3.
公开(公告)号:US20080167257A1
公开(公告)日:2008-07-10
申请号:US11673509
申请日:2007-02-09
申请人: Roderic M.K. Dale , Amy Arrow , Terry Thompson
发明人: Roderic M.K. Dale , Amy Arrow , Terry Thompson
CPC分类号: C12N15/1137 , A61K8/606 , A61K38/00 , A61K2800/74 , A61Q19/00 , C12N15/113 , C12N15/1136 , C12N15/1138 , C12N2310/11 , C12N2310/321 , C12N2320/35 , C12Y101/01088 , C12Y103/99005 , C12Y111/01006 , C12Y113/11012 , C12Y114/99001 , C12Y203/01026 , C12Y203/01085 , C12Y301/01003 , C12Y301/03048 , C12Y304/1401 , C12Y304/15001 , C12Y304/24011 , C12Y306/0301 , C12Y604/01002 , C12N2310/3521
摘要: The present invention relates to methods and compositions containing oligonucleotides suitable for administration to humans and other mammals.
摘要翻译: 本发明涉及含有适用于给予人和其它哺乳动物的寡核苷酸的方法和组合物。
-
公开(公告)号:US20090092659A1
公开(公告)日:2009-04-09
申请号:US12130405
申请日:2008-05-30
申请人: Roderic M.K. Dale , Steven L. Gatton , Amy Arrow
发明人: Roderic M.K. Dale , Steven L. Gatton , Amy Arrow
CPC分类号: A01N57/16 , A61B17/06166 , A61B2017/00893 , A61K8/606 , A61K31/70 , A61L15/46 , A61L17/005 , A61L17/04 , A61L17/105 , A61L24/0015 , A61L24/106 , A61L27/54 , A61L27/60 , A61L2300/258 , A61L2300/404 , A61Q19/00
摘要: The present invention provides devices and compositions for the management of infection of topical lesions, each of the devices and compositions containing protonated/acidified nucleic acids either on its surface, or integrated into the device. These modified nucleic acids are effective as bactericidal and/or bacteriostatic agents without regard to the class of bacteria, so are especially useful when diagnosis is difficult or when multiple infectious organisms are present. The antibiotic activity of nucleic acids of the invention is not dependent on either the specific sequence of the nucleic acid or the length of the nucleic acid molecule. The nucleic acids used in the invention are protonated/acidified to give a pH when dissolved in water of less than pH 7 to about 1, more preferably less than pH 4.5 to about 1, and even more preferably less than pH 2 to about 1.
摘要翻译: 本发明提供了用于管理局部损伤感染的装置和组合物,每个装置和组合物在其表面上含有质子化/酸化的核酸或整合到装置中。 这些修饰的核酸在不考虑细菌类的情况下作为杀菌剂和/或抑菌剂是有效的,因此当诊断困难时或当存在多种感染性生物时特别有用。 本发明的核酸的抗生素活性不依赖于核酸的特定序列或核酸分子的长度。 本发明中使用的核酸被质子化/酸化,当溶解在低于pH7至约1,更优选小于pH 4.5至约1,甚至更优选小于pH 2至约1的水中时产生pH。
-
5.
公开(公告)号:US20080234214A1
公开(公告)日:2008-09-25
申请号:US11673508
申请日:2007-02-09
申请人: Roderic M.K. Dale , Amy Arrow , Terry Thompson
发明人: Roderic M.K. Dale , Amy Arrow , Terry Thompson
IPC分类号: A61K31/7052 , A61P25/16 , A61P25/28
CPC分类号: C12N15/1137 , A61K8/606 , A61K38/00 , A61K2800/74 , A61Q19/00 , C12N15/113 , C12N15/1136 , C12N15/1138 , C12N2310/11 , C12N2310/321 , C12N2320/35 , C12Y101/01088 , C12Y103/99005 , C12Y111/01006 , C12Y113/11012 , C12Y114/99001 , C12Y203/01026 , C12Y203/01085 , C12Y301/01003 , C12Y301/03048 , C12Y304/1401 , C12Y304/15001 , C12Y304/24011 , C12Y306/0301 , C12Y604/01002 , C12N2310/3521
摘要: The present invention relates to methods and compositions containing oligonucleotides suitable for administration to humans and other mammals.
摘要翻译: 本发明涉及含有适用于给予人和其它哺乳动物的寡核苷酸的方法和组合物。
-
公开(公告)号:US5989912A
公开(公告)日:1999-11-23
申请号:US211795
申请日:1998-12-15
IPC分类号: C12N15/113 , C07H21/04 , C12N15/00 , C12Q1/68
CPC分类号: C12N15/113 , C12N2310/311 , C12N2310/315 , C12N2310/317 , C12N2310/321 , C12N2310/322 , C12N2310/346
摘要: This invention relates to antisense oligonucleotides that target mRNAs in cells as substrates for the cellular enzyme RNase H and thereby cause specific degradation of the targeted mRNA. The oligonucleotides have three components: a RNase H activating region, a complementarity region and 3' and 5' ends. The invention optimizes each of the components to resist intracellular nucleases, to increase hybridization to target mRNA, to specifically inactivate target mRNA in cells, and to decrease cytotoxicity.
摘要翻译: 本发明涉及靶细胞中的mRNA作为细胞酶RNase H底物的反义寡核苷酸,从而导致目标mRNA的特异性降解。 寡核苷酸具有三个组分:RNase H激活区,互补区和3'和5'末端。 本发明优化每种组分以抵抗细胞内核酸酶,增加与靶mRNA的杂交,以特异性地灭活细胞中的靶mRNA,并降低细胞毒性。
-
公开(公告)号:US06958239B2
公开(公告)日:2005-10-25
申请号:US09211794
申请日:1998-12-15
IPC分类号: C12N15/113 , C12N5/00 , C07H21/04
CPC分类号: C12N15/113 , C12N2310/311 , C12N2310/315 , C12N2310/317 , C12N2310/321 , C12N2310/322 , C12N2310/346 , C12N2310/3521 , C12N2310/3523 , C12N2310/3527
摘要: This invention relates to antisense oligonucleotides that target mRNAs in cells as substrates for the cellular enzyme RNase H and thereby cause specific degradation of the targeted mRNA. The oligonucleotides have three components: an RNase H activating region, a complementary region and 3′ and 5′ ends. The invention optimizes each of the components to resist intracellular nucleases, to increase hybridization to target mRNA, to specifically inactivate target mRNA in cells, and to decrease cytotoxicity.
摘要翻译: 本发明涉及靶细胞中的mRNA作为细胞酶RNase H底物的反义寡核苷酸,从而导致目标mRNA的特异性降解。 寡核苷酸具有三个组分:RNA酶H活化区,互补区和3'和5'末端。 本发明优化每种组分以抵抗细胞内核酸酶,增加与靶mRNA的杂交,以特异性地灭活细胞中的靶mRNA,并降低细胞毒性。
-
公开(公告)号:US07691996B2
公开(公告)日:2010-04-06
申请号:US11035693
申请日:2005-01-14
CPC分类号: C12N15/113 , C12N2310/311 , C12N2310/315 , C12N2310/317 , C12N2310/321 , C12N2310/322 , C12N2310/346 , C12N2310/3521 , C12N2310/3523 , C12N2310/3527
摘要: This invention relates to antisense oligonucleotides that target mRNAs in cells as substrates for the cellular enzyme RNase H and thereby cause specific degradation of the targeted mRNA. The oligonucleotides have three components: an RNase H activating region, a complementary region and 3′ and 5′ ends. The invention optimizes each of the components to resist intracellular nucleases, to increase hybridization to target mRNA, to specifically inactivate target mRNA in cells, and to decrease cytotoxicity.
摘要翻译: 本发明涉及靶细胞中的mRNA作为细胞酶RNase H底物的反义寡核苷酸,从而导致目标mRNA的特异性降解。 寡核苷酸具有三个组分:RNA酶H活化区,互补区和3'和5'末端。 本发明优化每种组分以抵抗细胞内核酸酶,增加与靶mRNA的杂交,以特异性地灭活细胞中的靶mRNA,并降低细胞毒性。
-
公开(公告)号:US20050202541A1
公开(公告)日:2005-09-15
申请号:US11035693
申请日:2005-01-14
申请人: Amy Arrow , Roderic Dale , Tod Woolf
发明人: Amy Arrow , Roderic Dale , Tod Woolf
IPC分类号: C12N15/113 , A61K48/00 , C07H21/02 , C12P19/34
CPC分类号: C12N15/113 , C12N2310/311 , C12N2310/315 , C12N2310/317 , C12N2310/321 , C12N2310/322 , C12N2310/346 , C12N2310/3521 , C12N2310/3523 , C12N2310/3527
摘要: This invention relates to antisense oligonucleotides that target mRNAs in cells as substrates for the cellular enzyme RNase H and thereby cause specific degradation of the targeted mRNA. The oligonucleotides have three components: an RNase H activating region, a complementary region and 3′ and 5′ ends. The invention optimizes each of the components to resist intracellular nucleases, to increase hybridization to target mRNA, to specifically inactivate target mRNA in cells, and to decrease cytotoxicity.
-
公开(公告)号:US08188259B2
公开(公告)日:2012-05-29
申请号:US11673508
申请日:2007-02-09
申请人: Roderic M. K. Dale , Amy Arrow , Terry Thompson
发明人: Roderic M. K. Dale , Amy Arrow , Terry Thompson
IPC分类号: C07H21/04
CPC分类号: C12N15/1137 , A61K8/606 , A61K38/00 , A61K2800/74 , A61Q19/00 , C12N15/113 , C12N15/1136 , C12N15/1138 , C12N2310/11 , C12N2310/321 , C12N2320/35 , C12Y101/01088 , C12Y103/99005 , C12Y111/01006 , C12Y113/11012 , C12Y114/99001 , C12Y203/01026 , C12Y203/01085 , C12Y301/01003 , C12Y301/03048 , C12Y304/1401 , C12Y304/15001 , C12Y304/24011 , C12Y306/0301 , C12Y604/01002 , C12N2310/3521
摘要: The present invention relates to methods and compositions containing oligonucleotides suitable for administration to humans and other mammals.
-
-
-
-
-
-
-
-
-